Us Physicalrapy Stock EBITDA

USPH Stock

USD 98.02 0.19 0.19%

US Physicalrapy fundamentals help investors to digest information that contributes to US Physicalrapy's financial success or failures. It also enables traders to predict the movement of USPH Stock. The fundamental analysis module provides a way to measure US Physicalrapy's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to US Physicalrapy stock.

		Last Reported	Projected for Next Year
	EBITDA	74.4 M	37.7 M

The current EBITDA is estimated to decrease to about 37.7 M.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

US Physicalrapy Company EBITDA Analysis

US Physicalrapy's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current US Physicalrapy EBITDA

74.37 M

Most of US Physicalrapy's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, US Physicalrapy is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

USPH EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for US Physicalrapy is extremely important. It helps to project a fair market value of USPH Stock properly, considering its historical fundamentals such as EBITDA. Since US Physicalrapy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of US Physicalrapy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of US Physicalrapy's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Good Will	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.77	0.91	0.78	0.54	0.98	0.91	0.93	0.99	-0.41	0.56	0.88	-0.34	0.91	0.06	0.07	-0.83	0.77	0.88	0.85	0.65	-0.89	0.82	0.83	0.51	0.77
Total Stockholder Equity	0.98		0.63	0.89	0.67	0.51	0.92	0.97	0.88	0.95	-0.46	0.61	0.82	-0.38	0.87	0.07	-0.02	-0.78	0.73	0.85	0.78	0.58	-0.82	0.82	0.8	0.63	0.85
Net Debt	0.77	0.63		0.74	0.92	0.49	0.87	0.48	0.81	0.81	-0.26	0.36	0.84	-0.24	0.77	0.11	0.15	-0.8	0.55	0.74	0.75	0.56	-0.81	0.57	0.72	0.02	0.32
Retained Earnings	0.91	0.89	0.74		0.75	0.76	0.87	0.75	0.79	0.89	-0.7	0.8	0.74	-0.66	0.72	0.32	-0.25	-0.67	0.75	0.71	0.83	0.66	-0.91	0.65	0.64	0.24	0.52
Accounts Payable	0.78	0.67	0.92	0.75		0.49	0.86	0.56	0.75	0.82	-0.38	0.46	0.9	-0.35	0.85	0.16	-0.01	-0.87	0.51	0.84	0.68	0.48	-0.76	0.52	0.75	0.18	0.39
Net Receivables	0.54	0.51	0.49	0.76	0.49		0.48	0.35	0.32	0.53	-0.74	0.83	0.41	-0.73	0.27	0.72	-0.43	-0.27	0.63	0.34	0.72	0.7	-0.68	0.26	0.34	-0.08	0.09
Total Liab	0.98	0.92	0.87	0.87	0.86	0.48		0.84	0.96	0.98	-0.34	0.48	0.93	-0.27	0.94	0.04	0.13	-0.9	0.7	0.91	0.83	0.6	-0.87	0.81	0.87	0.44	0.71
Total Current Assets	0.91	0.97	0.48	0.75	0.56	0.35	0.84		0.81	0.88	-0.36	0.51	0.78	-0.27	0.86	-0.03	0.0	-0.75	0.63	0.84	0.65	0.45	-0.66	0.82	0.79	0.8	0.95
Short Term Debt	0.93	0.88	0.81	0.79	0.75	0.32	0.96	0.81		0.92	-0.21	0.36	0.82	-0.15	0.9	-0.05	0.25	-0.83	0.62	0.81	0.79	0.56	-0.82	0.82	0.85	0.41	0.73
Intangible Assets	0.99	0.95	0.81	0.89	0.82	0.53	0.98	0.88	0.92		-0.36	0.51	0.92	-0.3	0.92	0.05	0.1	-0.88	0.74	0.91	0.85	0.65	-0.9	0.83	0.85	0.49	0.73
Good Will	-0.41	-0.46	-0.26	-0.7	-0.38	-0.74	-0.34	-0.36	-0.21	-0.36		-0.97	-0.3	0.99	-0.21	-0.63	0.83	0.2	-0.37	-0.24	-0.33	-0.25	0.39	-0.19	-0.16	-0.05	-0.13
Common Stock	0.56	0.61	0.36	0.8	0.46	0.83	0.48	0.51	0.36	0.51	-0.97		0.42	-0.94	0.35	0.69	-0.73	-0.33	0.49	0.38	0.51	0.4	-0.52	0.33	0.35	0.16	0.29
Long Term Debt	0.88	0.82	0.84	0.74	0.9	0.41	0.93	0.78	0.82	0.92	-0.3	0.42		-0.24	0.95	0.02	0.05	-0.97	0.58	0.96	0.68	0.48	-0.74	0.76	0.87	0.51	0.67
Treasury Stock	-0.34	-0.38	-0.24	-0.66	-0.35	-0.73	-0.27	-0.27	-0.15	-0.3	0.99	-0.94	-0.24		-0.13	-0.63	0.85	0.13	-0.33	-0.17	-0.28	-0.21	0.36	-0.11	-0.07	0.05	-0.02
Property Plant Equipment	0.91	0.87	0.77	0.72	0.85	0.27	0.94	0.86	0.9	0.92	-0.21	0.35	0.95	-0.13		-0.08	0.17	-0.97	0.55	0.96	0.68	0.44	-0.71	0.77	0.91	0.61	0.8
Current Deferred Revenue	0.06	0.07	0.11	0.32	0.16	0.72	0.04	-0.03	-0.05	0.05	-0.63	0.69	0.02	-0.63	-0.08		-0.59	0.02	0.13	-0.05	0.34	0.32	-0.13	-0.08	0.17	-0.24	-0.14
Short Term Investments	0.07	-0.02	0.15	-0.25	-0.01	-0.43	0.13	0.0	0.25	0.1	0.83	-0.73	0.05	0.85	0.17	-0.59		-0.11	0.03	0.09	0.16	0.17	-0.11	0.13	0.19	0.05	0.15
Net Tangible Assets	-0.83	-0.78	-0.8	-0.67	-0.87	-0.27	-0.9	-0.75	-0.83	-0.88	0.2	-0.33	-0.97	0.13	-0.97	0.02	-0.11		-0.51	-0.95	-0.64	-0.39	0.67	-0.72	-0.9	-0.52	-0.7
Total Permanent Equity	0.77	0.73	0.55	0.75	0.51	0.63	0.7	0.63	0.62	0.74	-0.37	0.49	0.58	-0.33	0.55	0.13	0.03	-0.51		0.57	0.8	0.77	-0.78	0.57	0.49	0.24	0.45
Long Term Debt Total	0.88	0.85	0.74	0.71	0.84	0.34	0.91	0.84	0.81	0.91	-0.24	0.38	0.96	-0.17	0.96	-0.05	0.09	-0.95	0.57		0.65	0.42	-0.71	0.71	0.86	0.63	0.77
Capital Surpluse	0.85	0.78	0.75	0.83	0.68	0.72	0.83	0.65	0.79	0.85	-0.33	0.51	0.68	-0.28	0.68	0.34	0.16	-0.64	0.8	0.65		0.87	-0.92	0.63	0.74	0.15	0.49
Deferred Long Term Liab	0.65	0.58	0.56	0.66	0.48	0.7	0.6	0.45	0.56	0.65	-0.25	0.4	0.48	-0.21	0.44	0.32	0.17	-0.39	0.77	0.42	0.87		-0.75	0.47	0.51	0.03	0.3
Accumulated Depreciation	-0.89	-0.82	-0.81	-0.91	-0.76	-0.68	-0.87	-0.66	-0.82	-0.9	0.39	-0.52	-0.74	0.36	-0.71	-0.13	-0.11	0.67	-0.78	-0.71	-0.92	-0.75		-0.63	-0.63	-0.13	-0.44
Short Long Term Debt	0.82	0.82	0.57	0.65	0.52	0.26	0.81	0.82	0.82	0.83	-0.19	0.33	0.76	-0.11	0.77	-0.08	0.13	-0.72	0.57	0.71	0.63	0.47	-0.63		0.77	0.58	0.77
Net Invested Capital	0.83	0.8	0.72	0.64	0.75	0.34	0.87	0.79	0.85	0.85	-0.16	0.35	0.87	-0.07	0.91	0.17	0.19	-0.9	0.49	0.86	0.74	0.51	-0.63	0.77		0.57	0.79
Net Working Capital	0.51	0.63	0.02	0.24	0.18	-0.08	0.44	0.8	0.41	0.49	-0.05	0.16	0.51	0.05	0.61	-0.24	0.05	-0.52	0.24	0.63	0.15	0.03	-0.13	0.58	0.57		0.9
Capital Stock	0.77	0.85	0.32	0.52	0.39	0.09	0.71	0.95	0.73	0.73	-0.13	0.29	0.67	-0.02	0.8	-0.14	0.15	-0.7	0.45	0.77	0.49	0.3	-0.44	0.77	0.79	0.9

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict US Physicalrapy

Ebitda Over Time

USPH Ebitda

Ebitda

37.73 Million

As of now, US Physicalrapy's EBITDA is increasing as compared to previous years.

According to the company disclosure, US Physicalrapy reported earnings before interest,tax, depreciation and amortization of 74.37 M. This is 91.52% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 98.09% higher than that of the company.

USPH EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses US Physicalrapy's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of US Physicalrapy could also be used in its relative valuation, which is a method of valuing US Physicalrapy by comparing valuation metrics of similar companies.

US Physicalrapy is currently under evaluation in ebitda category among its peers.

US Physicalrapy ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, US Physicalrapy's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to US Physicalrapy's managers, analysts, and investors.

Environmental

Governance

Social

US Physicalrapy Institutional Holders

Institutional Holdings refers to the ownership stake in US Physicalrapy that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of US Physicalrapy's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing US Physicalrapy's value.

		Shares
Geode Capital Management, Llc	2024-09-30	343.1 K
Riverbridge Partners Llc	2024-09-30	336.1 K
Gw&k Investment Management, Llc	2024-09-30	320 K
Envestnet Asset Management Inc	2024-09-30	249.6 K
Northern Trust Corp	2024-09-30	229.8 K
Fred Alger Management, Llc	2024-09-30	172.3 K
Fmr Inc	2024-09-30	164.5 K
Bank Of New York Mellon Corp	2024-06-30	157.1 K
Bank Of America Corp	2024-06-30	150.7 K
Morgan Stanley - Brokerage Accounts	2024-06-30	2.4 M
Blackrock Inc	2024-06-30	2.3 M

USPH Fundamentals

	Return On Equity	0.0475
	Return On Asset	0.0424
	Profit Margin	0.04 %
	Operating Margin	0.11 %
	Current Valuation	1.61 B
	Shares Outstanding	15.1 M
	Shares Owned By Insiders	1.58 %
	Shares Owned By Institutions	98.42 %
	Number Of Shares Shorted	597.87 K
	Price To Earning	34.35 X
	Price To Book	3.06 X
	Price To Sales	2.31 X
	Revenue	604.8 M
	Gross Profit	112.02 M
	EBITDA	74.37 M
	Net Income	37.22 M
	Cash And Equivalents	48.57 M
	Cash Per Share	3.73 X
	Total Debt	258.59 M
	Debt To Equity	0.57 %
	Current Ratio	1.43 X
	Book Value Per Share	32.02 X
	Cash Flow From Operations	81.98 M
	Short Ratio	6.03 X
	Earnings Per Share	0.88 X
	Price To Earnings To Growth	3.88 X
	Target Price	107.4
	Number Of Employees	3.9 K
	Beta	1.39
	Market Capitalization	1.48 B
	Total Asset	997.24 M
	Retained Earnings	223.77 M
	Working Capital	131.19 M
	Current Asset	60.18 M
	Current Liabilities	19.01 M
	Annual Yield	0.02 %
	Five Year Return	1.01 %
	Net Asset	997.24 M
	Last Dividend Paid	1.75

About US Physicalrapy Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze US Physicalrapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Physicalrapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Physicalrapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:

How To Invest In USPH

Details

Is USPH Stock a good investment?

Details

What is US Physicalrapy's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out US Physicalrapy Piotroski F Score and US Physicalrapy Altman Z Score analysis.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.24)

Dividend Share

1.75

Earnings Share

0.88

Revenue Per Share

42.489

Quarterly Revenue Growth

0.12

The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Us Physicalrapy Stock EBITDA

US Physicalrapy Company EBITDA Analysis

EBITDA

Revenue

-

Basic Expenses

Current US Physicalrapy EBITDA

USPH EBITDA Driver Correlations

USPH Ebitda

Ebitda

37.73 Million

USPH EBITDA Peer Comparison

US Physicalrapy ESG Sustainability

US Physicalrapy Institutional Holders

USPH Fundamentals

About US Physicalrapy Fundamental Analysis

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY